Multimodal Image Registration for Helping Laparoscopic Liver Surgery Guidance
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Sep 13, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to improve laparoscopic liver surgery, which is a minimally invasive technique where doctors use small instruments and a camera to operate on the liver. The researchers are looking at how different types of images—like ultrasound and CT scans—can be combined and enhanced using augmented reality. This technology helps surgeons see the exact location of hidden tumors during the operation, making the surgery safer and more precise. Ultimately, the goal is to help patients recover faster and reduce their time in the hospital.
To participate in this trial, you need to be an adult over 18 years old who is scheduled for a liver surgery called hepatectomy. You should also have good-quality imaging, like a CT scan or MRI, available for the doctors to use. The trial is currently recruiting participants, and both men and women are welcome to join. If you qualify, you can expect to have your surgery with this advanced imaging technology, which may lead to a quicker recovery and a better overall experience.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing hepatectomy;
- • Patients for whom good-quality imaging is available (CT scan and/or MRI and/or ultrasound);
- • Patients over 18 years of age;
- • Minimally invasive surgery by conventional or robot-assisted laparoscopy.
- Exclusion Criteria:
- • Surgery by laparotomy
About Centre Hospitalier Universitaire De Saint Etienne
The Centre Hospitalier Universitaire (CHU) de Saint-Étienne is a leading academic medical center in France, dedicated to advancing healthcare through innovative clinical research and high-quality patient care. With a robust infrastructure that supports a wide range of medical specialties, CHU de Saint-Étienne fosters collaboration between healthcare professionals, researchers, and academic institutions. The center is committed to conducting rigorous clinical trials that adhere to ethical standards and regulatory requirements, aiming to improve treatment outcomes and enhance the overall health of the community. Through its dedication to scientific excellence and patient-centered care, CHU de Saint-Étienne plays a pivotal role in the advancement of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint étienne, , France
Patients applied
Trial Officials
Bertrand LE ROY, MD PhD
Principal Investigator
CHU SAINT-ETIENNE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported